Variant proportions in the U.S.
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Help
Clear All

Query Builder

Query box

Help
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

i

Up-to-date Information

Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-nCoV/index.html

Variant proportions in the U.S.

Filetype[PDF-268.75 KB]


  • English

  • Details:

    • Description:
      Updated Apr. 6, 2021

      CDC’s national genomic surveillance program identifies new and emerging SARS-CoV-2 variants to determine implications for COVID-19 diagnostics, treatments, or vaccines authorized for use in the United States. Monitoring the spread of emerging variants in the United States relies on widespread, rapid sequencing. To accelerate sequencing in the United States, CDC has contracted with commercial diagnostic laboratories, and, in partnership with the Association of Public Health Laboratories (APHL), has implemented the National SARS-CoV-2 Strain Surveillance (NS3) program to provide a comprehensive and population-based US surveillance system.

      Based on these data, sequences with similar genetic changes associated with important epidemiological and biological events are grouped into lineages*, and the proportion of lineages circulating in the United Stated are tracked and characterized to determine if they are considered variants of concern (VOC) or variants of interest (VOI). Most of the lineages identified through genomic surveillance do not fall into either of these categories. These data, along with data from many other sources, are used to inform national and state public health actions related to variants.

    • Content Notes:
      Estimates of SARS-CoV-2 Prevalence -- Proportions of SARS-CoV-2 Variants of Concern by State.
    • Document Type:
    • Place as Subject:
    • Main Document Checksum:
    • File Type:

    Supporting Files

    More +

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov